Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination
Blood Cover Image for Volume 146, Issue 20
Current Issue
Volume 146,
Issue 20,
November 13 2025
View This Issue

Issue Highlights


Latest in Blood
Free Articles
FXR activation aids fibrinolysis: targeting PAI-1 in obesity Free
Alan J. Stewart
https://doi.org/10.1182/blood.2025030984
View All Free Articles
Plenary Papers
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial Available to Purchase
Juan José Lahuerta; Jesús San-Miguel; Ana Jiménez-Ubieto; Rafael Alonso; Bruno Paiva; Noemí Puig; M. Teresa Cedena; Norma Carmen Gutierrez; María José Calasanz; Manuela Fernández Guijarro; Rafael Ríos Tamayo; Albert Oriol Rocafiguera; María Jesús Blanchard; Estrella Carrillo Cruz; Rafael Martínez-Martínez; Joan Bargay; Ana Sureda Balari; Javier de la Rubia; Miguel Teodoro Hernández García; Valentín Cabañas; Felipe Casado Montero; Luis Palomera Bernal; Yolanda González Montes; Joaquín Martínez-Lopez; Paula Rodriguez-Otero; Isabel Krisnik; José M. Arguiñano; María Esther Gonzalez García; Enrique M. Ocio; Javier de la Cruz; María Victoria Mateos; Laura Rosiñol; Joan Bladé
https://doi.org/10.1182/blood.2025028313
View All Plenary Papers
First Edition
Integrin αvβ8-mediated TGF-β1 activation regulates sustained response in immune thrombocytopenia after TPO-RA withdrawal Open Access
Heng Mei; Min Xu; Jinhui jin Shu; Lu Tang; Qinying Xie; Lili Luo; Qiuzhe Wei; Huiwen Jiang; Zhangyin Ming; Yu Hu
https://doi.org/10.1182/blood.2025029769
View All First Edition Articles
Clinical Trials and Observations
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18 Open Access
Steven Knapper; Laura W Dillon; Malavika Babu; Abin Thomas; Ian Thomas; Christopher S Hourigan; Georgia M Andrew; Richard James Dillon; Amanda Frances Gilkes; Nuria Marquez-Almuina; Sophie King; Nicholas McCarthy; Reem Bahr; Rasha W Al-Ali; Louisa Stone; Tom Coats; Jennifer L Byrne; Simone Green; Ulrik Malthe Overgaard; Rob S. Sellar; Mike Dennis; Priyanka Mehta; Robert K Hills; Sylvie D Freeman; Nigel H. Russell
https://doi.org/10.1182/blood.2025031006
View All Clinical Trials and Observations

Advertisement intended for health care professionals

Over 165,000 citations
earned in 2024

ASH Commitment to Expansion and Inclusion in Hematology
Acknowledgement of Reviewers for 2024

Featured Content

High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial

Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics

Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma

Eliminating the need for sequential confirmation of response in multiple myeloma

T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals